Across TCGA pan-cancer cohorts, SLC4A11 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated SLC4A11 data layer compared with 4 for mutation status and 2 for mass-spec protein.
The strongest signal is observed in uveal melanoma (UVM), where higher SLC4A11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC4A11 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.
UVM, CESC, and SKCM are the cancer types where SLC4A11 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.